PetMed Express Inc (NAS:PETS)

Q4 2026 Petmed Express Inc Earnings Call Transcript

Jun 2, 2026 / 08:30 PM GMT

Release Date Price: $2.13 (-1.84%)

Transcript 10-K8-K

Key Points

Positve

PetMed Express Inc (PETS) made significant financial, operational, and cultural improvements in fiscal year 2026, aiming for sustainable long-term results.
The company regained critical regulatory compliance and improved internal controls, remediating three previously disclosed material weaknesses.
There was a sequential quarterly increase in fourth quarter net sales, marking the first Q4 sequential increase since fiscal year 2024.
Cost reduction efforts led to exiting underperforming vendor relationships, yielding approximately $6.1 million in annualized savings.
PetMed Express Inc (PETS) completed several important technology and infrastructure initiatives, including a new ERP system and fraud prevention system, enhancing operational efficiency.

Negative

Net sales for the full fiscal year 2026 were down 21.1%, with a 15.6% decline in the fourth quarter compared to the prior year.
The company reported a net loss of $57.3 million for the full fiscal year, significantly higher than the $6.3 million loss in the prior year.
Several significant non-recurring accounting entries, including a $26.7 million non-cash goodwill impairment and a $2.1 million wholesale inventory write-down, impacted financial results.
PetMed Express Inc (PETS) incurred $4.5 million in non-recurring legal, professional, and executive severance costs related to a whistleblower investigation.
Despite improvements, the company faced challenges with a decline in prescription medication sales, impacting overall revenue.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

PETS.OQ - Petmed Express Inc
Q4 2026 Petmed Express Inc Earnings Call
Jun 02, 2026 / 08:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Greetings and welcome to the PetMed Express Fiscal Fourth Quarter 2026 Financial Results Conference.

Time. All participants are in a listen-only mode. It's now my pleasure to introduce your host, Reed Anderson with ICR.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you, and welcome to the PetMed Express Fiscal Fourth Quarter 2026 Earnings Conference Call.

With us on the call today are Leslie Campbell, PetMed's Chairman, Interim CEO and President, and Doug Krulich, Interim Principal Financial Officer and Chief Accounting Officer.

Certain information

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.